Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 38% ± 12% | |
lung | 16 studies | 38% ± 15% | |
intestine | 12 studies | 34% ± 16% | |
brain | 10 studies | 26% ± 8% | |
kidney | 9 studies | 36% ± 10% | |
eye | 8 studies | 26% ± 12% | |
liver | 6 studies | 34% ± 20% | |
bone marrow | 5 studies | 31% ± 7% | |
pancreas | 4 studies | 39% ± 18% | |
placenta | 4 studies | 35% ± 22% | |
uterus | 4 studies | 37% ± 15% | |
lymph node | 4 studies | 40% ± 12% | |
breast | 4 studies | 24% ± 7% | |
adrenal gland | 3 studies | 30% ± 6% | |
esophagus | 3 studies | 48% ± 25% | |
skin | 3 studies | 22% ± 6% | |
thymus | 3 studies | 57% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6744.04 | 1445 / 1445 | 100% | 131.66 | 183 / 183 |
liver | 100% | 4829.99 | 226 / 226 | 100% | 109.32 | 406 / 406 |
ovary | 100% | 4215.20 | 180 / 180 | 100% | 170.08 | 430 / 430 |
stomach | 100% | 6590.65 | 359 / 359 | 100% | 160.96 | 286 / 286 |
uterus | 100% | 4571.81 | 170 / 170 | 100% | 154.99 | 459 / 459 |
breast | 100% | 5499.53 | 459 / 459 | 100% | 150.62 | 1116 / 1118 |
intestine | 100% | 8220.18 | 966 / 966 | 100% | 168.41 | 526 / 527 |
prostate | 100% | 4794.33 | 245 / 245 | 100% | 146.57 | 501 / 502 |
pancreas | 100% | 3569.15 | 327 / 328 | 100% | 107.16 | 178 / 178 |
thymus | 100% | 5574.03 | 652 / 653 | 100% | 140.12 | 604 / 605 |
kidney | 100% | 8293.09 | 89 / 89 | 100% | 138.03 | 898 / 901 |
brain | 100% | 5617.83 | 2633 / 2642 | 100% | 161.80 | 705 / 705 |
bladder | 100% | 5803.48 | 21 / 21 | 100% | 152.65 | 502 / 504 |
lung | 99% | 4818.48 | 574 / 578 | 100% | 131.68 | 1155 / 1155 |
skin | 100% | 6448.55 | 1807 / 1809 | 99% | 140.39 | 469 / 472 |
adrenal gland | 100% | 8529.04 | 258 / 258 | 98% | 101.85 | 226 / 230 |
adipose | 100% | 5562.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 183.88 | 29 / 29 |
muscle | 100% | 11554.91 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5370.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 162.00 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 50.72 | 1 / 1 |
blood vessel | 100% | 4892.19 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 13475.74 | 847 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 103.57 | 76 / 80 |
peripheral blood | 88% | 5591.92 | 819 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
GO_0021762 | Biological process | substantia nigra development |
GO_0042776 | Biological process | proton motive force-driven mitochondrial ATP synthesis |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0005753 | Cellular component | mitochondrial proton-transporting ATP synthase complex |
GO_0000276 | Cellular component | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0016020 | Cellular component | membrane |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0046933 | Molecular function | proton-transporting ATP synthase activity, rotational mechanism |
GO_0005515 | Molecular function | protein binding |
Gene name | ATP5PB |
Protein name | ATP synthase F(0) complex subunit B1, mitochondrial (ATP synthase peripheral stalk-membrane subunit b) (ATP synthase proton-transporting mitochondrial F(0) complex subunit B1) (ATP synthase subunit b) (ATPase subunit b) ATP synthase subunit b |
Synonyms | ATP5F1 |
Description | FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements. FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements. . |
Accessions | P24539 Q5QNZ2 ENST00000369722.8 ENST00000483994.1 |